Rallybio Corporation (RLYB) financial statements and ratios from SEC XBRL: revenue $858000.00 (TTM), net margin -1046.4%, revenue growth 0.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $858000.00 |
| Net Margin | -1046.4% |
| Revenue Growth (YoY) | 0.0% |
| EPS Growth (YoY) | 595.2% |
| Price / Book | 1.77 |
| Price / Sales | 103.99 |
| Altman Z-Score | 4.98 (safe) |
| Sector P/E (Healthcare) | 21.7 |
RLYB overview · RLYB earnings · RLYB KPIs · RLYB investor relations · RLYB ownership · RLYB peers · RLYB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.